Marcelle Goldner Cesca

544 total citations
18 papers, 272 citations indexed

About

Marcelle Goldner Cesca is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marcelle Goldner Cesca has authored 18 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marcelle Goldner Cesca's work include Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Marcelle Goldner Cesca is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Marcelle Goldner Cesca collaborates with scholars based in Brazil, Canada and Argentina. Marcelle Goldner Cesca's co-authors include Evandro de Azambuja, Sofia Cristóvão‐Ferreira, Solange Moraes Sanches, Vladmir Cláudio Cordeiro de Lima, Fernando Augusto Batista Campos, Isabel Cristina Gonçalves Leite, Alexandre André Balieiro Anastácio da Costa, Maria Nirvana Formiga, Erika Ruíz‐García and Romualdo Barroso‐Sousa and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Marcelle Goldner Cesca

16 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcelle Goldner Cesca Brazil 6 223 99 88 76 27 18 272
Yukie Fujimoto Japan 13 253 1.1× 106 1.1× 73 0.8× 59 0.8× 31 1.1× 20 331
Eric Thunnissen Netherlands 5 129 0.6× 62 0.6× 56 0.6× 122 1.6× 26 1.0× 6 223
Paw Christian Holdgaard Denmark 7 107 0.5× 116 1.2× 94 1.1× 120 1.6× 31 1.1× 15 252
Lucas Goldfarb France 7 187 0.8× 22 0.2× 154 1.8× 97 1.3× 20 0.7× 10 297
Mandar Karhade United States 10 217 1.0× 188 1.9× 22 0.3× 138 1.8× 79 2.9× 13 361
Myriam Taibi United States 3 373 1.7× 95 1.0× 33 0.4× 325 4.3× 40 1.5× 5 470
Danilo Galizia Italy 10 179 0.8× 68 0.7× 22 0.3× 108 1.4× 58 2.1× 32 285
Wanying Guo China 9 202 0.9× 83 0.8× 19 0.2× 52 0.7× 72 2.7× 12 279
Ruping Zhao China 10 89 0.4× 96 1.0× 26 0.3× 88 1.2× 121 4.5× 26 261
Lyudmila Zhukova Russia 7 201 0.9× 70 0.7× 35 0.4× 122 1.6× 58 2.1× 89 287

Countries citing papers authored by Marcelle Goldner Cesca

Since Specialization
Citations

This map shows the geographic impact of Marcelle Goldner Cesca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelle Goldner Cesca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelle Goldner Cesca more than expected).

Fields of papers citing papers by Marcelle Goldner Cesca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcelle Goldner Cesca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelle Goldner Cesca. The network helps show where Marcelle Goldner Cesca may publish in the future.

Co-authorship network of co-authors of Marcelle Goldner Cesca

This figure shows the co-authorship network connecting the top 25 collaborators of Marcelle Goldner Cesca. A scholar is included among the top collaborators of Marcelle Goldner Cesca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcelle Goldner Cesca. Marcelle Goldner Cesca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cesca, Marcelle Goldner, et al.. (2024). oss of CDX2 and high COX2 (PTGS2) expression in metastatic colorectal cancer. ecancermedicalscience. 18. 1666–1666. 1 indexed citations
2.
Rosa, Daniela Dornelles, Artur Katz, Daniele Xavier Assad, et al.. (2024). Cancer outcomes from a real-world cohort of patients eligible for adjuvant CDK4/6 inhibitors but without genomic risk for chemotherapy: A GBECAM multicenter retrospective study.. Journal of Clinical Oncology. 42(16_suppl). 540–540. 1 indexed citations
3.
Cesca, Marcelle Goldner, et al.. (2023). 481P Second generation oral selective estrogen receptor degraders (SERDs) in breast cancer: A systematic review and meta-analysis of clinical trials. Annals of Oncology. 34. S383–S383. 1 indexed citations
4.
5.
Cesca, Marcelle Goldner, Erika Ruíz‐García, Rui Weschenfelder, et al.. (2023). Influence of proton pump inhibitors on the pathological response of rectal cancer: a multicentre study. ecancermedicalscience. 17. 1586–1586. 2 indexed citations
6.
Figueiredo, Amanda Braga, Kátia L.P. Morais, Walderez O. Dutra, et al.. (2023). Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients. Frontiers in Immunology. 13. 1052104–1052104.
7.
Cesca, Marcelle Goldner, et al.. (2021). Combined endocrine and targeted therapy in luminal breast cancer. Expert Review of Anticancer Therapy. 21(11). 1237–1251. 12 indexed citations
8.
Cesca, Marcelle Goldner, et al.. (2021). HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer. Breast Cancer Research and Treatment. 190(1). 155–163. 107 indexed citations
9.
Jesus, Victor Hugo Fonseca de, et al.. (2021). HER2-low and gastric cancer: A prognostic biomarker?. Journal of Clinical Oncology. 39(15_suppl). e16086–e16086. 5 indexed citations
10.
Cesca, Marcelle Goldner, et al.. (2020). 256P Risk of CNS metastasis after neoadjuvant chemotherapy: Pathological complete response may not be enough. Annals of Oncology. 31. S342–S342. 1 indexed citations
11.
Cesca, Marcelle Goldner, et al.. (2020). HER2-positive advanced breast cancer treatment in 2020. Cancer Treatment Reviews. 88. 102033–102033. 84 indexed citations
12.
Costa, Alexandre André Balieiro Anastácio da, Marcelle Goldner Cesca, Henrique Mantoan, et al.. (2019). Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis. BMC Cancer. 19(1). 1194–1194. 5 indexed citations
13.
Cesca, Marcelle Goldner, et al.. (2019). Comparison of enzalutamide versus abiraterone in castration-resistant prostate cancer before docetaxel: Results of a propensity score-matched analysis.. Journal of Clinical Oncology. 37(15_suppl). e16540–e16540. 4 indexed citations
14.
Cesca, Marcelle Goldner, et al.. (2019). Solitary fibrous tumor: A Brazilian cohort analysis.. Journal of Clinical Oncology. 37(15_suppl). 11068–11068. 1 indexed citations
15.
Cesca, Marcelle Goldner, et al.. (2013). Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil. BMC Women s Health. 13(1). 6–6. 23 indexed citations
16.
Leite, Isabel Cristina Gonçalves, et al.. (2011). [Associated factors of lymphedema in breast cancer patients].. PubMed. 33(2). 75–80. 8 indexed citations
17.
Cesca, Marcelle Goldner, et al.. (2011). Voice analysis after cancer treatment with organ preservation. Head & Neck Oncology. 3(1). 19–19. 15 indexed citations
18.
Leite, Isabel Cristina Gonçalves, et al.. (2010). PARASITOSES INTESTINAIS: UMA REVISÃO SOBRE SEUS ASPECTOS SOCIAIS, EPIDEMIOLÓGICOS, CLÍNICOS E TERAPÊUTICOS Intestinal parasitic diseases: a review of social, epidemiologic, clinical and therapeutic aspects. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukie Fujimoto Breakdown of academic impact, for papers by Eric Thunnissen Breakdown of academic impact, for papers by Paw Christian Holdgaard Breakdown of academic impact, for papers by Lucas Goldfarb Breakdown of academic impact, for papers by Mandar Karhade Breakdown of academic impact, for papers by Myriam Taibi Breakdown of academic impact, for papers by Danilo Galizia Breakdown of academic impact, for papers by Wanying Guo Breakdown of academic impact, for papers by Ruping Zhao Breakdown of academic impact, for papers by Lyudmila Zhukova
Rankless by CCL
2026